You are here

Article Text

Article menu
Download PDFPDF
Therapeutics/Prevention
Systematic review
Staphylococcus aureus bacteraemia management: where do we stand and where are we going?

https://doi.org/10.1136/ebmed-2014-110122

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors PAM and GS were involved in the drafting and editing the commentary, and have approved the final submitted version.

    • Funding GS has received research grant support to his institution from Forrest and speaking honoraria from Cubist and Forest.

    • Competing interests PM is an employer and shareholder of Cubist Pharmaceuticals.

    • Provenance and peer review Commissioned; internally peer reviewed.